While there is a long-held belief that the ED is not an ideal setting to screen and treat patients with various substance use disorders, as emergency physicians, we have been trailblazers in the management of opioid use disorder
Following endogenous growth hormone release, downstream production of insulin-like growth factor-1 (IGF-1) contributes to many of the physiological processes associated with growth hormone biology
Long-term cancer risk in users of GLP-1 agonists in Denmark: a nationwide emulated trial
After four weeks, the dose can be increased to 7 mg or 14 mg, based on individual response and tolerability Wegovy (Injectable): The initial dose of Wegovy is generally 0.25 mg injected once weekly for four weeks
[1] Other documented side effects include injection site reactions, fatigue, hypoglycemia (particularly when used with insulin or insulin secretagogues), and increased heart rate